Search

You searched for "Chorioretinal"

365 results found

My experience of the transition into a specialist orthoptist role

1 August 2018 | | EYE - General
Michelle Dent discusses the process of transitioning into a new role and the pros and cons along the way. An opportunity arose for a permanent, full time, band 7 specialist role in the medical retina (MR) team in the Newcastle...

The role of aspirin in the treatment of NAION: Benefits and controversies

4 December 2024 | | EYE - Neuro-ophthalmology
Non-arteritic anterior ischaemic optic neuropathy (NAION) is the most common acute optic neuropathy in individuals over 50 with estimated prevalence of 2–10 per 100,000 people, characterised by sudden, unilateral vision loss due to ischaemic injury to the optic nerve head....

Conference Report: OSI Dry Eye Masterclass & Symposium 2025: A first-hand experience

6 June 2025 | | News, Events, Meetings, Report, Ocular Surface Insight
The Ocular Surface Insight (OSI) Dry Eye Masterclass & Symposium took place on the 27th and 28th of March 2025 at the Copthorne Tara Hotel in London, with the attendance of 186 delegates, bringing together experts, researchers, and clinicians from...
Last Minute Optics book cover image.

Last-Minute Optics, Second Edition

2 August 2022 | | EYE - General
For those who shudder at the thought of clinical optics, this is the book for you. Dr Hunter’s second edition of Last-Minute Optics is a resource for more than just last-minute cramming, despite its title. It provides a real-life perspective...

Coming to terms with AI

1 August 2019 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...

PACK-crosslinking for infectious keratitis

1 October 2015 | | EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...

The results of the last survey Apr23

3 April 2023 | | EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. My thanks...

Understanding and confronting bacterial endophthalmitis

2 December 2019 | | EYE - Cornea, EYE - Vitreo-Retinal, EYE - General
Abdus Samad Ansari highlights the importance of early recognition of this condition using an unusual presentation. Endophthalmitis is a medical emergency with devastating consequences. Despite adequate treatment, severe cases frequently result in permanent blindness. Endophthalmitis involves inflammation of both the...

A paradigm shift in the way we approach cataract surgery

1 February 2015 | | EYE - Cataract, EYE - Refractive
Cataract surgery is the most common elective surgical procedure in the UK [1], with in the region of 350,000 cases being conducted each year. With an ageing population, this figure will only continue to rise over time. Cataract surgery is...

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

7 December 2020 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - Oculoplastic, EYE - General
The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Unconscious bias (part 2)

5 February 2020 | | EYE - General
Does unconscious bias exist, and does training help to reduce discriminatory behaviour? Clare Inkster questions her role as a trainer. I read Gwyn Williams’ Learning Curve article on this topic a few months ago with interest, and as someone who...